The re-import of Vitamin B1 to China is forecasted to grow steadily from $271.83K in 2024 to $327.53K in 2028. As of 2023, the actual re-import value stood at $257K. This projection represents a continuous upward trend, with a year-on-year average increase of approximately 5.2% over the forecasted period. The compound annual growth rate (CAGR) over the next five years is anticipated at approximately 4.6%.
Future trends to watch for:
- Continued demand growth linked to the increasing health supplement market in China.
- Potential regulatory changes that could impact import dynamics.
- Emerging biotechnologies that may influence the production and supply chain of Vitamin B1.
